An Open-label, Randomised, Multicentre, Multi-country Three-arm Study of the Treatment with Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 14 days versus Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. for 10 days versus Clarithromycin 500 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 10 Days in Patients with Helicobacter pylori infection. Finafloxacin in patients with Helicobacter: The FLASH 2 Study.

Trial Profile

An Open-label, Randomised, Multicentre, Multi-country Three-arm Study of the Treatment with Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 14 days versus Finafloxacin 400 mg b.i.d. plus Esomeprazole 40 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. for 10 days versus Clarithromycin 500 mg b.i.d. plus Amoxicillin 1000 mg b.i.d. plus Esomeprazole 40 mg b.i.d. for 10 Days in Patients with Helicobacter pylori infection. Finafloxacin in patients with Helicobacter: The FLASH 2 Study.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Apr 2013

At a glance

  • Drugs Amoxicillin; Clarithromycin; Esomeprazole; Finafloxacin
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Acronyms FLASH2
  • Most Recent Events

    • 21 Apr 2012 Additional location (Germany) added as reported by European Clinical Trials Database.
    • 16 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top